Glaxo Sues Israeli Drug Maker For Trademark Infringement

Law360, New York (February 9, 2004, 12:00 AM EST) -- GlaxoSmithKline is suing Israeli drug maker Dexxon in the Tel Aviv District Court, asking the court to bar the use of the name Zanidex for a generic version of its Zantac indigestion drug.

The U.K. drug maker is seeking a permanent injunction, an order to present accounts, and a mandatory injunction against generic drug manufacturers and marketers Dexxon and Dexal.

The complaint asserts that Dexxon and Dexal named their generic version Zanidex, closely resembling the name of the original drug, in an attempt to exploit the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.